Next Article in Journal
Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain
Next Article in Special Issue
Renal Side Effects of Non-Steroidal Anti-Inflammatory Drugs in Neonates
Previous Article in Journal
Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound
Previous Article in Special Issue
Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: An Update
Open AccessArticle

Structural Examination of 6-Methylsulphonylphenanthro- [9,10-C]-furan-1(3H)-one—A Rofecoxib Degradation Product

Department of Chemistry, Monash University, Wellington Road, Clayton, Victoria, 3800, Australia
Pharmaceuticals 2010, 3(2), 369-378; https://doi.org/10.3390/ph3020369
Received: 14 December 2009 / Revised: 12 January 2010 / Accepted: 21 January 2010 / Published: 1 February 2010
(This article belongs to the Special Issue Non-Steroidal Anti-Inflammatory Drugs)
In the attempt to discover a new polymorph of rofecoxib (Vioxx®), an unexpected product resulted. The product was characterised by chemical composition, thermal behaviour and structure and found to be 6-methylsulphonylphenanthro-[9,10-C] furan-1(3H)-one, a photo-cyclization degradation product of rofecoxib. This is a significant finding because it indicates that without appropriate control of the recrystallisation procedures, the structural integrity of rofecoxib may be seriously compromised. View Full-Text
Keywords: rofecoxib; structural characterisation; NSAID; crystallography rofecoxib; structural characterisation; NSAID; crystallography
Show Figures

Graphical abstract

MDPI and ACS Style

Dean, P.M. Structural Examination of 6-Methylsulphonylphenanthro- [9,10-C]-furan-1(3H)-one—A Rofecoxib Degradation Product. Pharmaceuticals 2010, 3, 369-378.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop